This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Marrie, R. A. Articles by Vollmer, T. Search for Related Content PubMed PubMed Citation Articles by Marrie, R. A. Articles by Vollmer, T. Social Bookmarking                   What's this?

Validation of the NARCOMS Registry: pain assessment

Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH, USA, marrier{at}ccf.org

Gary Cutter

Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA

Tuula Tyry

Division of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA

Olympia Hadjimichael

Department of Neurology, Yale University Medical School, New Haven, CT, USA

Timothy Vollmer

Division of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA

The North American Research Committee on Multiple Sclerosis (NARCOMS) Registry is a multiple sclerosis (MS) self-report registry with more than 24 000 participants. Participants report disability status upon enrolment, and semi-annually using Performance Scales (PS), Patient Determined Disease Steps (PDDS) and a pain question. In November 2000 and 2001, we also collected the Pain Effects Scale (PES). Our aim was to validate the NARCOMS pain question using the PES as our criterion measure. We measured correlations between the pain question and age, disease duration, various PS subscales and PDDS to assess construct validity. We correlated pain question responses in participants who reported no change in PDSS or the PS subscales between questionnaires to determine test—retest reliability. We measured responsiveness in participants who reported a substantial change in the sensory, spasticity PS subscales. The correlation between the pain question and PES was r=0.61 in November 2000, and r=0.64 in November 2001 (both P<0.0001). Correlations between the pain question and age, and disease duration were low, indicating divergent validity. Correlations between the pain question and spasticity, sensory PS subscales and PDSS were moderate, indicating convergent validity. Test—retest reliability was r=0.84 (P<0.0001). Responsiveness was 70.7%. The pain question is a valid self-report measure of pain in MS.

Key Words: multiple sclerosis • pain • registry • reliability • self-report • validity

Multiple Sclerosis, Vol. 11, No. 3, 338-342 (2005)
DOI: 10.1191/1352458505ms1167oa


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Andreasen, J Jakobsen, T Petersen, and H Andersen Fatigued patients with multiple sclerosis have impaired central muscle activation Multiple Sclerosis, July 1, 2009; 15(7): 818 - 827. [Abstract] [PDF]

				R. Marrie, R Horwitz, G Cutter, T Tyry, D Campagnolo, and T Vollmer High frequency of adverse health behaviors in multiple sclerosis Multiple Sclerosis, January 1, 2009; 15(1): 105 - 113. [Abstract] [PDF]

				R.A. Marrie, G. Cutter, T. Tyry, D. Campagnolo, and T. Vollmer Validation of the NARCOMS registry: diagnosis Multiple Sclerosis, July 1, 2007; 13(6): 770 - 775. [Abstract] [PDF]